NARI Inari Medical

Inari Medical to Present at the J.P. Morgan Healthcare Conference

Inari Medical to Present at the J.P. Morgan Healthcare Conference

IRVINE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other vascular diseases, announced today that its management team is scheduled to present at the J.P. Morgan Healthcare Conference on Wednesday, January 15 at 8:15 a.m. Pacific Time.

Interested parties may access a live webcast and replay of the presentation by visiting the Inari Medical investor relations .

About Inari Medical, Inc.

Patients first. No small plans. Take care of each other. These are the guiding principles that form the ethos of Inari Medical. We are committed to improving lives in extraordinary ways by creating innovative solutions for both unmet and underserved health needs. In addition to our purpose-built solutions, we leverage our capabilities in education, clinical research, and program development to improve patient outcomes. We are passionate about our mission to establish our treatments as the standard of care for venous thromboembolism and four other targeted disease states. We are just getting started. Learn more at and connect with us on , , and .

Inari Medical contact:

Neil Bhalodkar





EN
03/01/2025

Underlying

NARIInari Medical

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Inari Medical

 PRESS RELEASE
Free
NARI INARI MEDICAL

Inari Medical to Present at the J.P. Morgan Healthcare Conference

Inari Medical to Present at the J.P. Morgan Healthcare Conference IRVINE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other vascular diseases, announced today that its management team is scheduled to present at the J.P. Morgan Healthcare Conference on Wednesday, January 15 at 8:15 a.m. Pacific Time. Interested parties may access a live webcast and replay of the presentation by visiting the Inari Medical investor relations . About Inari ...

January 3, 2025 1 EN
 PRESS RELEASE
Free
NARI INARI MEDICAL

Inari Medical Announces Reimbursement Approval for ClotTriever® Thromb...

Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd. Reimbursement approval supports expanded access to effective, safe thrombus removal for patients suffering from deep vein thrombosis (DVT) in Japan IRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other vascular diseases, announced today that on December 1, 2024, it received national r...

December 2, 2024 1 EN
 PRESS RELEASE
Free
NARI INARI MEDICAL

Inari Medical Announces Joint Venture in Greater China

Inari Medical Announces Joint Venture in Greater China IRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced it has entered into a joint venture with 6 Dimensions Capital (“6 Dimensions”) and its successor fund 120 Capital, and VFLO Medical (“VFLO”), a medical device platform incubated by 6 Dimensions and 120 Capital, to provide access to Inari’s innovative technology for patients with significant unmet nee...

December 2, 2024 1 EN
 PRESS RELEASE
Free
NARI INARI MEDICAL

Inari Medical to Participate in the Jefferies London Healthcare Confer...

Inari Medical to Participate in the Jefferies London Healthcare Conference IRVINE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today its management team will present at the upcoming Jefferies London Healthcare Conference on Wednesday, November 20, 2024, at 10:00 AM Greenwich Mean Time / 5:00 AM Eastern Time. A live audio webcast and replay of the presentation may be accessed for 30 days on the “Investor Relati...

November 6, 2024 1 EN
 PRESS RELEASE
Free
NARI INARI MEDICAL

PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter...

PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism Primary endpoint win driven by both hard clinical outcomes and hospital resource utilization IRVINE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced positive results from the prospective PEERLESS Randomized Controlled Trial (RCT) comparing FlowTriever to catheter-directed th...

October 29, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch